{{Rsnum
|rsid=11604671
|Gene=ANKK1
|Chromosome=11
|position=113397337
|Orientation=plus
|GMAF=0.2571
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ANKK1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 20.6 | 54.0 | 25.4
| HCB | 0.0 | 11.1 | 88.9
| JPT | 0.0 | 11.4 | 88.6
| YRI | 0.0 | 4.8 | 95.2
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 11.1 | 88.9
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19796663
|Title=Influence of DRD2 and ANKK1 genotypes on apomorphine-induced growth hormone (GH) response in alcohol-dependent patients
}}

{{PMID Auto
|PMID=18698520
|Title=Single nucleotide polymorphisms in ANKK1 and the dopamine D2 receptor gene affect cognitive outcome shortly after traumatic brain injury: a replication and extension study.
|OA=1
}}

{{PMID Auto
|PMID=20133381
|Title=Sex differences in TTC12/ANKK1 haplotype associations with daily tobacco smoking in Black and White Americans.
|OA=1
}}

{{PMID Auto
|PMID=20452395
|Title=Association of functional variants in the dopamine D2-like receptors with risk for gambling behaviour in healthy Caucasian subjects.
}}

{{GET Evidence
|gene=ANKK1
|aa_change=Gly318Arg
|aa_change_short=G318R
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs11604671
|overall_frequency_n=3881
|overall_frequency_d=10522
|overall_frequency=0.368846
|n_genomes=25
|n_genomes_annotated=0
|n_haplomes=30
|n_articles=0
|n_articles_annotated=0
|pph2_score=0.006
|nblosum100=6
|autoscore=0
|webscore=N
}}

{{PMID Auto
|PMID=22893251
|Title=Influence of ANKK1 and DRD2 polymorphisms in response to haloperidol.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}